MedPath

Clinical observation on the treatment of type IIIB prostatitis by combining YiqiHuoXueTuoDu Formula with modified abdominal and anal retracting and lifting exercise

Early Phase 1
Conditions
Prostatitis IIIB
Registration Number
ITMCTR2023000033
Lead Sponsor
Xiyuan Hospital, China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

1. Meanwhile, it meets the requirements of ?B prostatitis diagnostic standard of modern medicine and Chinese medicine;
2. Male patients aged between 18 and 50 years old;
3. not undergoing prostatitis-related treatment within two weeks prior to enrolment;
4. Patients who voluntarily joined the study, had good compliance and signed the informed consent document.

Exclusion Criteria

1. Persons with a history of allergy to the test drug or low blood pressure and intolerance to the drug;
2. those with severe primary cardiovascular lesions, liver lesions, renal lesions, haematological lesions, pulmonary diseases, or serious diseases affecting their survival, such as tumours or AIDS, which are considered by the investigator to be inappropriate for enrolment. Liver function ALT, AST, renal function BUN more than 50% of the upper limit of normal value, renal function Cr more than the upper limit of normal value, will not be enrolled.
3. Those with severe obstructive diseases of the urinary tract that require surgical treatment;
4. Combined with severe mental and spiritual changes that make it difficult to communicate and cooperate;
5. Patients with other organic diseases of the prostate, such as prostate tumour, benign prostatic hyperplasia, etc.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IH-CPSI;
Secondary Outcome Measures
NameTimeMethod
GAD-7;PHQ-9;PSEP;Chronic Prostatitis Chinese Medicine Symptoms Scale;EMG;
© Copyright 2025. All Rights Reserved by MedPath